A large observational study has found that men taking tadalafil daily for enlarged prostate symptoms face a meaningfully elevated risk of developing glaucoma — a condition that can quietly steal sight before it is noticed. The findings, drawn from nearly 74,000 men tracked over five years, remind us that medicines designed to ease one burden sometimes introduce another, and that the body's systems are more entangled than any single prescription can account for. Researchers are not calling for the drug to be abandoned, but for the kind of watchful care that long-term treatment demands.
Tadalafil linked to elevated glaucoma risk in men with enlarged prostates
Potential vision loss and blindness risk for men with enlarged prostates taking tadalafil long-term, particularly those with pre-existing glaucoma risk factors.